Volume 23: Issue 5 (Dec 2024): Transplantation

Wiebe C, Nickerson PW: Role of HLA molecular mismatch in clinical practice. Hum Immunol 83: 219–224, 2022 PubMed

• PubMed
Wiebe C, Nickerson PW: Role of HLA molecular mismatch in clinical practice. Hum Immunol 83: 219–224, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Schinstock CA, Askar M, Bagnasco SM, Batal I, Bow L, Budde K, et al.: A 2020 Banff Antibody-mediated Injury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - A cohort study. Transpl Int 34: 488–498, 2021 PubMed

• PubMed
Schinstock CA, Askar M, Bagnasco SM, Batal I, Bow L, Budde K, : A 2020 Banff Antibody-mediated Injury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - A cohort study. Transpl Int 34: 488–498, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Callemeyn J, Lamarthee B, Koenig A, Koshy P, Thaunat O, Naesens M: Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 101: 692–710, 2022 PubMed

• PubMed
Callemeyn J, Lamarthee B, Koenig A, Koshy P, Thaunat O, Naesens M: Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 101: 692–710, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Naesens M, Roufosse C, Haas M, Lefaucheur C, Mannon RB, Adam BA, et al.: The Banff 2022 kidney meeting report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am J Transplant 24: 338–349, 2024 PubMed

• PubMed
Naesens M, Roufosse C, Haas M, Lefaucheur C, Mannon RB, Adam BA, : The Banff 2022 kidney meeting report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am J Transplant 24: 338–349, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Callemeyn J, Ameye H, Lerut E, Senev A, Coemans M, Van Loon E, et al.: Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. Am J Transplant 21: 2413–2423, 2021 PubMed

• PubMed
Callemeyn J, Ameye H, Lerut E, Senev A, Coemans M, Van Loon E, : Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. Am J Transplant 21: 2413–2423, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Banff meeting report writing committee, et al.: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14: 272–283, 2014 PubMed

• PubMed
Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Banff meeting report writing committee, : Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14: 272–283, 2014 PubMed)| false
• Search Google Scholar
• Export Citation

Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312–2323, 2009 PubMed

• PubMed
Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312–2323, 2009 PubMed)| false
• Search Google Scholar
• Export Citation

Varol H, Ernst A, Cristoferi I, Arns W, Baan CC, van Baardwijk M, et al.: Feasibility and potential of transcriptomic analysis using the NanoString nCounter technology to aid the classification of rejection in kidney transplant biopsies. Transplantation 107: 903–912, 2023 PubMed

• PubMed
Varol H, Ernst A, Cristoferi I, Arns W, Baan CC, van Baardwijk M, : Feasibility and potential of transcriptomic analysis using the NanoString nCounter technology to aid the classification of rejection in kidney transplant biopsies. Transplantation 107: 903–912, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Rosales IA, Mahowald GK, Tomaszewski K, Hotta K, Iwahara N, Otsuka T, et al.: Banff human organ transplant transcripts correlate with renal allograft pathology and outcome: Importance of capillaritis and subpathologic rejection. J Am Soc Nephrol 33: 2306–2319, 2022 PubMed

• PubMed
Rosales IA, Mahowald GK, Tomaszewski K, Hotta K, Iwahara N, Otsuka T, : Banff human organ transplant transcripts correlate with renal allograft pathology and outcome: Importance of capillaritis and subpathologic rejection. J Am Soc Nephrol 33: 2306–2319, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Tambur AR, Bestard O, Campbell P, Chong AS, Barrio MC, Ford ML, et al.: Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting report. Am J Transplant 23: 133–149, 2023 PubMed

• PubMed
Tambur AR, Bestard O, Campbell P, Chong AS, Barrio MC, Ford ML, : Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting report. Am J Transplant 23: 133–149, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Rampersad C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, et al.: The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant 22: 761–771, 2022 PubMed

• PubMed
Rampersad C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, : The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant 22: 761–771, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Mehta RB, Melgarejo I, Viswanathan V, Zhang X, Pittappilly M, Randhawa P, et al.: Long-term immunological outcomes of early subclinical inflammation on surveillance kidney allograft biopsies. Kidney Int 102: 1371–1381, 2022 PubMed

• PubMed
Mehta RB, Melgarejo I, Viswanathan V, Zhang X, Pittappilly M, Randhawa P, : Long-term immunological outcomes of early subclinical inflammation on surveillance kidney allograft biopsies. Kidney Int 102: 1371–1381, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

El Ters M, Grande JP, Keddis MT, Rodrigo E, Chopra B, Dean PG, et al.: Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant 13: 2334–2341, 2013 PubMed

• PubMed
El Ters M, Grande JP, Keddis MT, Rodrigo E, Chopra B, Dean PG, : Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant 13: 2334–2341, 2013 PubMed)| false
• Search Google Scholar
• Export Citation

Madill-Thomsen KS, Böhmig GA, Bromberg J, Einecke G, Eskandary F, Gupta G, the INTERCOMEX Investigators, et al.: Relating molecular T cell-mediated rejection activity in kidney transplant biopsies to time and to histologic tubulitis and atrophy-fibrosis. Transplantation 107: 1102–1114, 2023 PubMed

• PubMed
Madill-Thomsen KS, Böhmig GA, Bromberg J, Einecke G, Eskandary F, Gupta G, the INTERCOMEX Investigators, : Relating molecular T cell-mediated rejection activity in kidney transplant biopsies to time and to histologic tubulitis and atrophy-fibrosis. Transplantation 107: 1102–1114, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Agrawal A, Balakrishnan S, Gandhi MJ, Alexander MP, Cornell L, Bentall AJ, et al.: Highly sensitized candidates remain at risk for microvascular inflammation even when donor-specific antibody is avoided: A matched cohort study. Transplantation 108: 1986–1993, 2024 PubMed

• PubMed
Agrawal A, Balakrishnan S, Gandhi MJ, Alexander MP, Cornell L, Bentall AJ, : Highly sensitized candidates remain at risk for microvascular inflammation even when donor-specific antibody is avoided: A matched cohort study. Transplantation 108: 1986–1993, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Beadle J, Papadaki A, Toulza F, Santos E, Willicombe M, McLean A, et al.: Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection. Kidney Int 104: 526–541, 2023 PubMed

• PubMed
Beadle J, Papadaki A, Toulza F, Santos E, Willicombe M, McLean A, : Application of the Banff Human Organ Transplant Panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection. Kidney Int 104: 526–541, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Halloran PF, Madill-Thomsen KS, Pon S, Sikosana MLN, Böhmig GA, Bromberg J, INTERCOMEX Investigators, et al.: Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes. Am J Transplant 22: 1976–1991, 2022 PubMed

• PubMed
Halloran PF, Madill-Thomsen KS, Pon S, Sikosana MLN, Böhmig GA, Bromberg J, INTERCOMEX Investigators, : Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes. Am J Transplant 22: 1976–1991, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Gauthier P, the Trifecta Investigators, et al.: Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: Results from the Trifecta Study. Transplantation 107: 709–719, 2023 PubMed

• PubMed
Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Gauthier P, the Trifecta Investigators, : Antibody-mediated rejection without detectable donor-specific antibody releases donor-derived cell-free DNA: Results from the Trifecta Study. Transplantation 107: 709–719, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Buxeda A, Llinàs-Mallol L, Gimeno J, Redondo-Pachón D, Arias-Cabrales C, Burballa C, et al.: Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration. Am J Transplant 23: 464–474, 2023 PubMed

• PubMed
Buxeda A, Llinàs-Mallol L, Gimeno J, Redondo-Pachón D, Arias-Cabrales C, Burballa C, : Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration. Am J Transplant 23: 464–474, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Bu L, Gupta G, Pai A, Anand S, Stites E, Moinuddin I, et al.: Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int 101: 793–803, 2022 PubMed

• PubMed
Bu L, Gupta G, Pai A, Anand S, Stites E, Moinuddin I, : Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int 101: 793–803, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Huang E, Haas M, Gillespie M, Sethi S, Peng A, Najjar R, et al.: An assessment of the value of donor-derived cell-free DNA surveillance in patients with preserved kidney allograft function. Transplantation 107: 274–282, 2023 PubMed

• PubMed
Huang E, Haas M, Gillespie M, Sethi S, Peng A, Najjar R, : An assessment of the value of donor-derived cell-free DNA surveillance in patients with preserved kidney allograft function. Transplantation 107: 274–282, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Aubert O, Ursule-Dufait C, Brousse R, Gueguen J, Racapé M, Raynaud M, et al.: Cell-free DNA for the detection of kidney allograft rejection. Nat Med 30: 2320–2327, 2024 PubMed

• PubMed
Aubert O, Ursule-Dufait C, Brousse R, Gueguen J, Racapé M, Raynaud M, : Cell-free DNA for the detection of kidney allograft rejection. Nat Med 30: 2320–2327, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Billings P, Trifecta Investigators, et al.: The Trifecta Study: Comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol 33: 387–400, 2022 PubMed

• PubMed
Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Billings P, Trifecta Investigators, : The Trifecta Study: Comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol 33: 387–400, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Park S, Guo K, Heilman RL, Poggio ED, Taber DJ, Marsh CL, et al.: Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients. Clin J Am Soc Nephrol 16: 1539–1551, 2021 PubMed

• PubMed
Park S, Guo K, Heilman RL, Poggio ED, Taber DJ, Marsh CL, : Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients. Clin J Am Soc Nephrol 16: 1539–1551, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Hirt-Minkowski P, Handschin J, Stampf S, Hopfer H, Menter T, Senn L, et al.: Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine. J Am Soc Nephrol 34: 1456–1469, 2023 PubMed

• PubMed
Hirt-Minkowski P, Handschin J, Stampf S, Hopfer H, Menter T, Senn L, : Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine. J Am Soc Nephrol 34: 1456–1469, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Ho J, Schaub S, Jackson AM, Balshaw R, Carroll R, Cun S, et al.: Multicenter validation of a urine CXCL10 assay for noninvasive monitoring of renal transplants. Transplantation 107: 1630–1641, 2023 PubMed

• PubMed
Ho J, Schaub S, Jackson AM, Balshaw R, Carroll R, Cun S, : Multicenter validation of a urine CXCL10 assay for noninvasive monitoring of renal transplants. Transplantation 107: 1630–1641, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D, ESOT Working Group Subclinical DSA Monitoring, et al.: The clinical utility of post-transplant monitoring of donor-specific antibodies in stable renal transplant recipients: A consensus report with guideline statements for clinical practice. Transpl Int 36: 11321, 2023 PubMed

• PubMed
van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D, ESOT Working Group Subclinical DSA Monitoring, : The clinical utility of post-transplant monitoring of donor-specific antibodies in stable renal transplant recipients: A consensus report with guideline statements for clinical practice. Transpl Int 36: 11321, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Wiebe C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, et al.: A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression. Am J Transplant 23: 1882–1892, 2023 PubMed

• PubMed
Wiebe C, Balshaw R, Gibson IW, Ho J, Shaw J, Karpinski M, : A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression. Am J Transplant 23: 1882–1892, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Raynaud M, Al-Awadhi S, Louis K, Zhang H, Su X, Goutaudier V, et al.: Prognostic biomarkers in kidney transplantation: A systematic review and critical appraisal. J Am Soc Nephrol 35: 177–188, 2024 PubMed

• PubMed
Raynaud M, Al-Awadhi S, Louis K, Zhang H, Su X, Goutaudier V, : Prognostic biomarkers in kidney transplantation: A systematic review and critical appraisal. J Am Soc Nephrol 35: 177–188, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Ho J, Okoli GN, Rabbani R, Lam OLT, Reddy VK, Askin N, et al.: Effectiveness of T cell-mediated rejection therapy: A systematic review and meta-analysis. Am J Transplant 22: 772–785, 2022 PubMed

• PubMed
Ho J, Okoli GN, Rabbani R, Lam OLT, Reddy VK, Askin N, : Effectiveness of T cell-mediated rejection therapy: A systematic review and meta-analysis. Am J Transplant 22: 772–785, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Koshy P, Furian L, Nickerson P, Zaza G, Haller M, de Vries APJ, et al.: European survey on clinical practice of detecting and treating T-cell mediated kidney transplant rejection. Transpl Int 37: 12283, 2024 PubMed

• PubMed
Koshy P, Furian L, Nickerson P, Zaza G, Haller M, de Vries APJ, : European survey on clinical practice of detecting and treating T-cell mediated kidney transplant rejection. Transpl Int 37: 12283, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Aziz F, Parajuli S, Garg N, Mohamed M, Zhong W, Djamali A, et al.: How should acute T-cell mediated rejection of kidney transplants be treated: Importance of follow-up biopsy. Transplant Direct 8: e1305, 2022 PubMed

• PubMed
Aziz F, Parajuli S, Garg N, Mohamed M, Zhong W, Djamali A, : How should acute T-cell mediated rejection of kidney transplants be treated: Importance of follow-up biopsy. Transplant Direct 8: e1305, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Fernando SC, Polkinghorne KR, Lim WH, Mulley WR: Early versus late acute AMR in kidney transplant recipients—A comparison of treatment approaches and outcomes from the ANZDATA Registry. Transplantation 107: 2424–2432, 2023 PubMed

• PubMed
Fernando SC, Polkinghorne KR, Lim WH, Mulley WR: Early versus late acute AMR in kidney transplant recipients—A comparison of treatment approaches and outcomes from the ANZDATA Registry. Transplantation 107: 2424–2432, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, et al.: Recommended treatment for antibody-mediated rejection after kidney transplantation: The 2019 expert consensus from the Transplantion Society Working Group. Transplantation 104: 911–922, 2020 PubMed

• PubMed
Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, : Recommended treatment for antibody-mediated rejection after kidney transplantation: The 2019 expert consensus from the Transplantion Society Working Group. Transplantation 104: 911–922, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, et al.: Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. Kidney Int 91: 729–737, 2017 PubMed

• PubMed
Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, : Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. Kidney Int 91: 729–737, 2017 PubMed)| false
• Search Google Scholar
• Export Citation

Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, et al.: A randomized phase 2 trial of felzartamab in antibody-mediated rejection. N Engl J Med 391: 122–132, 2024 PubMed

• PubMed
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, : A randomized phase 2 trial of felzartamab in antibody-mediated rejection. N Engl J Med 391: 122–132, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Loupy A, Mengel M, Haas M: Thirty years of the International Banff Classification for Allograft Pathology: The past, present, and future of kidney transplant diagnostics. Kidney Int 101: 678–691, 2022 PubMed

• PubMed
Loupy A, Mengel M, Haas M: Thirty years of the International Banff Classification for Allograft Pathology: The past, present, and future of kidney transplant diagnostics. Kidney Int 101: 678–691, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Chancharoenthana W, Traitanon O, Leelahavanichkul A, Tasanarong A: Molecular immune monitoring in kidney transplant rejection: A state-of-the-art review. Front Immunol 14: 1206929, 2023 PubMed

• PubMed
Chancharoenthana W, Traitanon O, Leelahavanichkul A, Tasanarong A: Molecular immune monitoring in kidney transplant rejection: A state-of-the-art review. Front Immunol 14: 1206929, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Halloran PF, Madill-Thomsen KS, Reeve J: The molecular phenotype of kidney transplants: Insights from the MMDx project. Transplantation 108: 45–71, 2024 PubMed

• PubMed
Halloran PF, Madill-Thomsen KS, Reeve J: The molecular phenotype of kidney transplants: Insights from the MMDx project. Transplantation 108: 45–71, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, et al.: Banff 2019 meeting report: Molecular diagnostics in solid organ transplantation—Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 20: 2305–2317, 2020 PubMed

• PubMed
Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, : Banff 2019 meeting report: Molecular diagnostics in solid organ transplantation—Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 20: 2305–2317, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Shi T, Burg AR, Caldwell JT, Roskin K, Castro-Rojas CM, Chukwuma PC, et al.: Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality [published online ahead of print Feb 13 2023]. bioRxiv, doi:10.1101/2023.02.08.524808 PubMed

• PubMed
Shi T, Burg AR, Caldwell JT, Roskin K, Castro-Rojas CM, Chukwuma PC, : Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality [published online ahead of print Feb 13 2023]. bioRxiv, doi:10.1101/2023.02.08.524808 PubMed)| false
• Search Google Scholar
• Export Citation

Tasca P, van den Berg BM, Rabelink TJ, Wang G, Heijs B, van Kooten C, et al.: Application of spatial-omics to the classification of kidney biopsy samples in transplantation. Nat Rev Nephrol 20: 755–766, 2024 PubMed

• PubMed
Tasca P, van den Berg BM, Rabelink TJ, Wang G, Heijs B, van Kooten C, : Application of spatial-omics to the classification of kidney biopsy samples in transplantation. Nat Rev Nephrol 20: 755–766, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Hirai T, Kondo A, Shimizu T, Fukuda H, Tokita D, Takagi T, et al.: Unveiling spatial immune cell profile in kidney allograft rejections using 36-plex immunofluorescence imaging [published online ahead of print Jun 24 2024]. Transplantation, doi:10.1097/TP.0000000000005107 PubMed

• PubMed
Hirai T, Kondo A, Shimizu T, Fukuda H, Tokita D, Takagi T, : Unveiling spatial immune cell profile in kidney allograft rejections using 36-plex immunofluorescence imaging [published online ahead of print Jun 24 2024]. Transplantation, doi:10.1097/TP.0000000000005107 PubMed)| false
• Search Google Scholar
• Export Citation

Cristoferi I, Varol H, van Baardwijk M, Rahiem L, Lila KA, van den Bosch TPP, et al.: Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass. Kidney Int 105: 812–823, 2024 PubMed

• PubMed
Cristoferi I, Varol H, van Baardwijk M, Rahiem L, Lila KA, van den Bosch TPP, : Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass. Kidney Int 105: 812–823, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Shah Y, Yang H, Mueller FB, Li C, Gul Rahim SE, Varma E, et al.: Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts. Kidney Int 105: 347–363, 2024 PubMed

• PubMed
Shah Y, Yang H, Mueller FB, Li C, Gul Rahim SE, Varma E, : Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts. Kidney Int 105: 347–363, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Van Loon E, Lamarthée B, de Loor H, Van Craenenbroeck AH, Brouard S, Danger R, et al.: Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney Int 102: 183–195, 2022 PubMed

• PubMed
Van Loon E, Lamarthée B, de Loor H, Van Craenenbroeck AH, Brouard S, Danger R, : Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney Int 102: 183–195, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Leventhal JR, Galvin J, Ison MG, Feng CY, Ding R, Lee JR, et al.: Evaluation of immunocompetence and biomarkers of tolerance in chimeric and immunosuppression-free kidney allograft recipients. Transplantation 107: e257–e268, 2023 PubMed

• PubMed
Leventhal JR, Galvin J, Ison MG, Feng CY, Ding R, Lee JR, : Evaluation of immunocompetence and biomarkers of tolerance in chimeric and immunosuppression-free kidney allograft recipients. Transplantation 107: e257–e268, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Senev A, Tambur AR, Kosmoliaptsis V, Copley HC, García-Sánchez C, Usenko C, et al.: HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation. Front Immunol 15: 1377535, 2024 PubMed

• PubMed
Senev A, Tambur AR, Kosmoliaptsis V, Copley HC, García-Sánchez C, Usenko C, : HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation. Front Immunol 15: 1377535, 2024 PubMed)| false
• Search Google Scholar
• Export Citation

Kant S, Kaufman DB, Micsa L, Brennan DC: Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: The MDR-105-SAE. Trials 24: 178, 2023 PubMed

• PubMed
Kant S, Kaufman DB, Micsa L, Brennan DC: Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: The MDR-105-SAE. Trials 24: 178, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Guinan EC, Contreras-Ruiz L, Crisalli K, Rickert C, Rosales I, Makar R, et al.: Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial. Am J Transplant 23: 1872–1881, 2023 PubMed

• PubMed
Guinan EC, Contreras-Ruiz L, Crisalli K, Rickert C, Rosales I, Makar R, : Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial. Am J Transplant 23: 1872–1881, 2023 PubMed)| false
• Search Google Scholar
• Export Citation

Schaier M, Morath C, Wang L, Kleist C, Opelz G, Tran TH, et al.: Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation. Front Immunol 14: 1089664, 2023 PubMed

• PubMed
Schaier M, Morath C, Wang L, Kleist C, Opelz G, Tran TH, : Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation. Front Immunol 14: 1089664, 2023 PubMed)| false
• Search Google Scholar
• Export Citation